文献速递肝病

细胞毒性分子颗粒酶B与TRAIL在硬化性胆管炎免疫发病机制中的拮抗作用

Antagonistic effects of the cytotoxic molecules granzyme B and TRAIL in the immunopathogenesis of sclerosing cholangitis.
PubMed 文献 · Hepatology · 2024-03-05

该研究在原发性硬化性胆管炎患者样本和Mdr2-/-小鼠中,用单细胞RNA测序等技术发现CD8+ T细胞和NK细胞的颗粒酶B与TRAIL表达升高;敲除Gzmb减轻胆管细胞凋亡、肝损伤和纤维化,而敲除Tnfsf10加重硬化性胆管炎。

要点

  • 硬化性胆管炎中CD8+ T细胞和NK细胞的颗粒酶B与TRAIL表达升高。
  • 敲除Gzmb减少Mdr2-/-小鼠胆管细胞凋亡、肝损伤和纤维化。
  • 敲除Tnfsf10加重Mdr2-/-小鼠硬化性胆管炎,TRAIL具保护作用。

核心结论

  • 颗粒酶B在硬化性胆管炎中诱导凋亡和纤维化,而TRAIL调节炎症和细胞毒性免疫反应,从而减少肝损伤和纤维化。

研究设计与样本

  • 研究使用原发性硬化性胆管炎患者样本和Mdr2-/-小鼠,采用单细胞RNA测序、转录组与表位联合细胞索引测序分析及多参数流式细胞术。
  • 通过Mdr2-/- × Gzmb-/-和Mdr2-/- × Tnfsf10-/-小鼠研究GzmB和TRAIL对疾病进展的意义。

主要发现

  • 在硬化性胆管炎中,CD8+ T细胞和NK细胞的GzmB和TRAIL表达增加。
  • 清除CD8+ T细胞改善Mdr2-/-小鼠疾病严重程度。
  • 缺乏GzmB导致胆管细胞凋亡、肝损伤和纤维化减少。
  • 缺乏TRAIL时硬化性胆管炎加重,与CD8+ T细胞和NK细胞GzmB及干扰素γ表达升高、T细胞存活增强、胆管细胞凋亡和扩增增加相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by biliary inflammation and fibrosis. We showed an elevated interferon γ response in patients with primary sclerosing cholangitis and in multidrug resistance protein 2-deficient ( Mdr2-/- ) mice developing sclerosing cholangitis. Interferon γ induced expression of the cytotoxic molecules granzyme B (GzmB) and TRAIL in hepatic lymphocytes and mediated liver fibrosis in sclerosing cholangitis. APPROACH AND RESULTS: In patient samples and Mdr2-/- mice, we identified lymphocyte clusters with a cytotoxic gene expression profile using single-cell RNA-seq and cellular indexing of transcriptomes and epitopes by sequencing analyses combined with multi-parameter flow cytometry. CD8 + T cells and NK cells showed increased expression of GzmB and TRAIL in sclerosing cholangitis. Depletion of CD8 + T cells ameliorated disease severity in Mdr2-/- mice. By using Mdr2-/- × Gzmb-/- and Mdr2-/- × Tnfsf10-/- mice, we investigated the significance of GzmB and TRAIL for disease progression in sclerosing cholangitis. Interestingly, the lack of GzmB resulted in reduced cholangiocyte apoptosis, liver injury, and fibrosis. In contrast, sclerosing cholangitis was aggravated in the absence of TRAIL. This correlated with elevated GzmB and interferon γ expression by CD8 + T cells and NK cells enhanced T-cell survival, and increased apoptosis and expansion of cholangiocytes. CONCLUSIONS: GzmB induces apoptosis and fibrosis in sclerosing cholangitis, whereas TRAIL regulates inflammatory and cytotoxic immune responses, subsequently leading to reduced liver injury and fibrosis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Kellerer M, Javed S, Casar C, et al. Antagonistic effects of the cytotoxic molecules granzyme B and TRAIL in the immunopathogenesis of sclerosing cholangitis. Hepatology. 2024. PMID: 38441998. doi:10.1097/HEP.0000000000000830

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。